Products Categories
    Product Certification&
    Enterprise Certification

  • Mr.Jack Shen
    Tel: +86-571-86758373

  • Mobile:
  • Tel:+86-571-86758373
  • Fax:
  • URL:http://www.huarongpharm.com
  • Province/state:Zhejiang
  • City:Hangzhou
  • Street:Room1707, 7Th Floor, Xin Chuanmei Industry Building , No.58 of Xintang Road, Jianggan District, Hangzhou, China.
  • MaxCard:
Home > Products >  Nilotinib Hcl

Nilotinib Hcl CAS NO.923288-90-8

  • FOB Price: USD: /Gram Get Latest Price
  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T
  • Available Specifications:

    99% (1-2)Gram99% (2-5)Gram99.9%(1-2)Gram

  • Product Details

Keywords

  • Nilotinib Hcl
  • Nilotinib
  • Nilotinib Hcl Monohydrate

Quick Details

  • ProName: Nilotinib Hcl
  • CasNo: 923288-90-8
  • Molecular Formula: C28H25ClF3N7O2
  • Appearance: Off-White Powder
  • Application: Used for the treatment of type 2 diabe...
  • DeliveryTime: 20 day
  • PackAge: Aluminium bag & Paper Drum
  • Port: Shanghai
  • ProductionCapacity: 500 Kilogram/Month
  • Purity: 99%
  • Storage: Normal temperature
  • Transportation: Normal condition
  • LimitNum: 1 Kilogram
  • Related Substances: Less than 1.0%
  • Residue on Ignition: Less than 0.1%
  • Heavy Metal: 20 ppm
  • Valid Period: 24 months
  • DMF: Available

Superiority

1. USDMF is available.

2. CEP is available.

3. KDMF would be available soon.

 

Huarong Industrial Group Limited established since 2006 , has been actively developing specialty products for Finished Dosages, APIs, Intermediates, and Fine chemicals markets in North America, Europe, Korea, Japan, Mid-East and all over the World.

 

Huarong Group has a team of more than 15 professionals working with diligence and tenacity at all hours trying to make a breakthrough and leap to the industry and yours. In addition to the distribution, Huarong people have invested in Lab and cGMP plants to allows us to offer service like: develop non-infringing synthesis process(include impurity study, stability study novel polymorph forms,ect) ,technology transfer, with a view to the long-term supply to support FTF In US, EU, China and other markets.


Huarong people has built our success through the success of our clients by providing complete solutions. As our belief to be your “China Business Partner & Solution", we are looking forward to establishing a long term cooperation with our partners and clients all over the world.

Details

1. USDMF is available.

2. CEP is available.

3. KDMF would be available soon.

Huarong Industrial Group Limited established since 2006 , has been actively developing specialty products for Finished Dosages, APIs, Intermediates, and Fine chemicals markets in North America, Europe, Korea, Japan, Mid-East and all over the World.

 

Huarong Group has a team of more than 15 professionals working with diligence and tenacity at all hours trying to make a breakthrough and leap to the industry and yours. In addition to the distribution, Huarong people have invested in Lab and cGMP plants to allows us to offer service like: develop non-infringing synthesis process(include impurity study, stability study novel polymorph forms,ect) ,technology transfer, with a view to the long-term supply to support FTF In US, EU, China and other markets.


Huarong people has built our success through the success of our clients by providing complete solutions. As our belief to be your “China Business Partner & Solution", we are looking forward to establishing a long term cooperation with our partners and clients all over the world.

 

Sitagliptin phosphate is dipeptidyl peptidase Ⅳ(DDP-4) inhibitor class of drugs developed by the German Merck company and firstly obtained the US Food and Drug Administration approval for the treatment of type 2 diabetes, is a new antidiabetic drug, can improve the body's own ability to reduce high blood glucose levels, and the relatively increase naturally occurring incretin by inhibiting the activity of this enzyme, including the levels of glucagon-like peptide 1 and glucose-dependent insulinotropic peptide, thereby triggering the pancreas to improve insulin production and stop glucose production in liver, and ultimately reduce the clinical effect of blood glucose concentration. Features of this product is to stimulate insulin secretion, at the same time can alleviate hunger, but does not make weight gain, and also cannot happen hypoglycemia and edema, is not suitable for use in diabetic patients with poor glycemic control and often developed hypoglycemia. But the drug should not be used for treatment of patients with type 1 diabetes or diabetic ketoacidosis.

Other products of this supplier

lookchemhot product CAS New CAS